Logo_AIHTA
  • Deutsch
  • Contact
    • Imprint
      • Privacy Notice
        • Newsletter
          • Sitemap
            Menu_button
            • News
              • About us
                • Research areas
                  • Research Projects
                    • Publications
                      • Search
                        • Announcements
                          • Events
                            • Newsletter
                              • Press release on our reports
                                • Press photos
                                  Video
                                  Video: What is HTA?    
                                  • Home
                                  • News

                                  News

                                  Leiste32


                                  Welcome to the homepage of AIHTA!

                                  AIHTA is an academic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                  In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                  Subscribe to newsletter

                                  Fotolia-168399976-s

                                  Announcement

                                  Screening for fetal trisomies 21, 18 and 13 by non-invasive prenatal testing (NIPT). EUnetHTA report

                                  Since several years, numerous new non-invasive prenatal tests (NIPTs) have been available to identify common chromosomal anomalies. Most NIPTs are available for trisomies 21, 18 and 13 and sex chromosome aneuploidies, but many laboratories have expanded their range of analysis to include other trisomies and common microdeletions. The main advantage of NIPT compared to the conventional screening approach is the ease of implementation and non-invasiveness of the assay, as well as the potential reduction in false-positive [FP] results. An introduction of non-invasive genetic testing has ethical, social and organizational implications that need to be considered.

                                  Publication: LBI-HTA Project report No. 103: https://eprints.aihta.at/1153/

                                  Contact: Claudia Wild

                                  More...

                                  2133

                                  Announcement

                                  Horizon Scanning in Oncology - Reports

                                  We are pleased to introduce our new HSO report.

                                  DSD HSO No. 77
                                  Alectinib as monotherapy for the first-line treatment of adult patients with ALK-positive advanced non-small cell lung cancer (NSCLC)

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • „Sauber und transparent“ – Medizinprodukte-Branche gibt sich strengere Regeln
                                  • Versorgung von Frühgeborenen an der Grenze der Lebensfähigkeit
                                  • Perkutaner Aortenklappenersatz – Kosteneffektivitätsvergleich & Einsatz in Österreich
                                  • Psychotherapie – Wirkfaktoren und gesetzliche Regelungen
                                  • Kinder- und Jugendgesundheit: Social Return on Investment
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  Jb-2017a1

                                  Announcement

                                  Annual Report 2017 online

                                  Download PDF

                                  More...

                                  Fotolia-113482237-s

                                  Announcement

                                  MammaPrint® Added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer. EunetHTA report

                                  MammaPrint®  is a test that measures the activity of certain genes within the tumour cells to estimate the likelihood of the tumour to return and spread to other organs, where it becomes incurable. Based on the outcome of MammaPrint®, depending whether the tumour has a low or high risk of returning, and in consultation with the clinician, it can be determined whether or not additional chemotherapy is needed after surgery. This 'gene expression test' is analysing the activity of 70 genes in the breast tumour and claims to be a tumour fingerprint.

                                  Publication: LBI-HTA Project report No.102: https://eprints.aihta.at/1147

                                  Contact: Claudia Wild

                                  More...

                                  Nicu-fotolia-106055878-m2

                                  Announcement

                                  Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs)

                                  Due to the medical advances in neonatal intensive care medicine, the survival rate of premature infants has increased over the last two decades with babies born after 22 weeks of gestation now having a chance of survival. Based on interviews with five heads of Austrian perinatal care centers and a clinical ethicist, this literature review outlines the current evidence on decision-making practices (guidelines, good practice models, and communication strategies) and ethical challenges at the limit of viability.

                                  Publication: LBI-HTA Projekt report No. 97b:  https://eprints.aihta.at/1148/

                                  Contact: Michal Stanak

                                  More...

                                  Nicu-fotolia-106055878-m1

                                  Announcement

                                  Perinatal care at the threshold of viability; Part I: Systematic Analysis of Outcomes and Resource Needs for Neonatal Intensive Care Units to inform Healthcare Planning

                                  Due to the medical advances in neonatal intensive care medicine, the survival rate of premature infants has increased over the last two decades, with babies born after 22 weeks of gestation now having a chance of survival. In a systematic review, recent data on survival and survival without impairment for extremely preterm infants was collected, as well as literature on resource needs in neonatal intensive care units (NICUs). In addition, interviews with five heads of Austrian perinatal care centers provide insights into the current supply situation in Austrian NICUs.

                                  Publication: LBI-HTA Project report No. 97a: https://eprints.aihta.at/1146/

                                  Contact : Katharina Hawlik

                                  More...

                                  2132

                                  Announcement

                                  Horizon Scanning in Oncology - Reports

                                  We are pleased to introduce our two new HSO reports.

                                  DSD HSO No. 76
                                  Durvalumab (Imfinzi™) for the treatment of patients with stage III non-small-cell lung cancer after prior chemoradiotherapy

                                  DSD HSO No. 75
                                  Nivolumab (Opdivo®) for metastatic DNA mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer (CRC)

                                  More...

                                  Fotolia-85470270-m

                                  Announcement

                                  Psychotherapy - concepts, effect factors and a German-speaking country comparison of legal regulations

                                  Psychotherapy developed on the basis of various sciences (e.g., medicine or psychology) and became an independent scientific discipline with specific methods. Against this background, the report is based on concepts used in German-speaking countries as well as general and specific effect factors in psychotherapy. Furthermore, differences in the German-speaking area are presented in the legally recognized psychotherapeutic methods for the outpatient sector as well as the legal framework conditions for the recognition of new psychotherapeutic methods, vocational training and professional practice in psychotherapy.

                                  Publication: LBI-HTA Project report No. 93: https://eprints.aihta.at/1143/

                                  Contact: Katharina Rosian

                                  More...

                                  Fotolia-83601192-m1

                                  Announcement

                                  Social Return on Investment: Outcomes, Methods, and Economic Parameters

                                  Social Return On Investment measures the social „value for money“ of an intervention. In our project, though, we are providing an overview of studies measuring the return on investment of 15 health-related interventions from the societal perspective. The studies have shown that all interventions are worth the investment. Thus, the savings are higher than the costs of the interventions. The highest returns can be expected in the areas of “crime” and “income”.

                                  Publication: LBI-HTA Project report No. 96: https://eprints.aihta.at/1142/

                                  Contact: Stefan Fischer

                                  More...

                                  « < ... 27 28 29 30 31 ... > »
                                  Displaying results 281 to 290.
                                  • News
                                    • Announcements
                                      • Events
                                        • Newsletter
                                          • Press release on our reports
                                            • Press photos
                                            • About us
                                              • Evaluation
                                                • History
                                                  • Methods
                                                    • Team
                                                      • Shareholder & organization chart
                                                        • Stakeholder involvement
                                                          • Press clippings
                                                          • Research areas
                                                            • Oncology
                                                              • High tech medicine
                                                                • Rehabilitation and occupational therapy
                                                                  • Prevention and screening
                                                                    • Psychological & psychiatric interventions
                                                                      • Health economics
                                                                        • European collaboration
                                                                          • HTA-methods & steering instruments
                                                                            • Complementary medicine
                                                                            • Research Projects
                                                                              • Synopsis of current research projects
                                                                                • Synopsis of completed research projects
                                                                                  • Decision Support Documents for the Austrian Appraisal Board
                                                                                    • HTA-Information Service Rapid Reviews
                                                                                      • Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
                                                                                        • Horizon Scanning of Medicines - Reports and Fact Sheets
                                                                                          • Horizon Scanning in Oncology – support for a budget-impact-calculation
                                                                                            • Evaluation of individual medical procedures - Reports
                                                                                              • All projects in an overview
                                                                                              • Publications
                                                                                                • Repository
                                                                                                  • HTA-Newsletter
                                                                                                    • Annual Reports
                                                                                                    • Search
                                                                                                      Netzwerk
                                                                                                      • Eunethta
                                                                                                      • Ebm
                                                                                                      • Inahta
                                                                                                      • Dexhelpp
                                                                                                      Shareholder
                                                                                                      • Bmfg
                                                                                                      • Sv
                                                                                                      • Wgfond
                                                                                                      • Noe
                                                                                                      • Ooghfond
                                                                                                      • Ghls
                                                                                                      • Tirol
                                                                                                      • Vorarlberg
                                                                                                      • Kghfond
                                                                                                      • Ghpf
                                                                                                      • Burgef
                                                                                                      • Contact
                                                                                                        • Imprint
                                                                                                          • Privacy Notice
                                                                                                            • Newsletter
                                                                                                              • Sitemap
                                                                                                                © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                • Log in